Nasdaq
MYGN
Myriad Genetics, Inc.
- Health Care
- Listed 1995
- 1 day
- +1.0%
- 1 month
- −45.7%
- 1 year
- −43.9%
$3.18 · Mkt cap $304M
At the 6 Aug 2026 close
Nasdaq
Myriad Genetics, Inc.
$3.18 · Mkt cap $304M
At the 6 Aug 2026 close
Myriad Genetics, Inc. trades under the ticker MYGN on Nasdaq, in the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances). It has been listed since 1995. Its market capitalisation is $304M. The last closing price was $3.18, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −43.9%, and −45.7% over the past month. Returns are price returns and exclude dividends.
This page exists because MYGN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.